nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—ovarian cancer	0.483	1	CbGaD
Perindopril—ABCB1—Topotecan—ovarian cancer	0.0549	0.354	CbGbCtD
Perindopril—ABCB1—Vinorelbine—ovarian cancer	0.0387	0.249	CbGbCtD
Perindopril—ABCB1—Paclitaxel—ovarian cancer	0.0272	0.175	CbGbCtD
Perindopril—ABCB1—Docetaxel—ovarian cancer	0.0197	0.127	CbGbCtD
Perindopril—BCHE—diaphragm—ovarian cancer	0.0175	0.195	CbGeAlD
Perindopril—ABCB1—Doxorubicin—ovarian cancer	0.0147	0.0945	CbGbCtD
Perindopril—ACE—vein—ovarian cancer	0.0146	0.163	CbGeAlD
Perindopril—SLC15A1—epithelium—ovarian cancer	0.00315	0.0352	CbGeAlD
Perindopril—SLC15A1—endometrium—ovarian cancer	0.00282	0.0315	CbGeAlD
Perindopril—ACE—embryo—ovarian cancer	0.00276	0.0309	CbGeAlD
Perindopril—ACE—epithelium—ovarian cancer	0.00226	0.0252	CbGeAlD
Perindopril—ACE—decidua—ovarian cancer	0.00213	0.0238	CbGeAlD
Perindopril—BCHE—myometrium—ovarian cancer	0.00212	0.0237	CbGeAlD
Perindopril—SLC15A1—vagina—ovarian cancer	0.00211	0.0236	CbGeAlD
Perindopril—ACE—endometrium—ovarian cancer	0.00202	0.0226	CbGeAlD
Perindopril—SLC15A2—uterine cervix—ovarian cancer	0.00195	0.0218	CbGeAlD
Perindopril—ACE—gonad—ovarian cancer	0.00188	0.021	CbGeAlD
Perindopril—SLC15A2—endometrium—ovarian cancer	0.00176	0.0197	CbGeAlD
Perindopril—ACE—female reproductive system—ovarian cancer	0.00168	0.0187	CbGeAlD
Perindopril—BCHE—uterine cervix—ovarian cancer	0.00165	0.0185	CbGeAlD
Perindopril—ACE—bone marrow—ovarian cancer	0.00158	0.0177	CbGeAlD
Perindopril—ACE—female gonad—ovarian cancer	0.00152	0.017	CbGeAlD
Perindopril—BCHE—endometrium—ovarian cancer	0.00149	0.0167	CbGeAlD
Perindopril—SLC15A2—female reproductive system—ovarian cancer	0.00146	0.0163	CbGeAlD
Perindopril—BCHE—uterus—ovarian cancer	0.00138	0.0154	CbGeAlD
Perindopril—ACE—testis—ovarian cancer	0.00135	0.0151	CbGeAlD
Perindopril—SLC15A2—female gonad—ovarian cancer	0.00133	0.0149	CbGeAlD
Perindopril—SLC15A2—vagina—ovarian cancer	0.00132	0.0148	CbGeAlD
Perindopril—BCHE—female reproductive system—ovarian cancer	0.00124	0.0138	CbGeAlD
Perindopril—SLC15A2—testis—ovarian cancer	0.00118	0.0132	CbGeAlD
Perindopril—BCHE—bone marrow—ovarian cancer	0.00117	0.0131	CbGeAlD
Perindopril—BCHE—vagina—ovarian cancer	0.00112	0.0125	CbGeAlD
Perindopril—ABCB1—myometrium—ovarian cancer	0.00101	0.0113	CbGeAlD
Perindopril—BCHE—testis—ovarian cancer	0.000999	0.0112	CbGeAlD
Perindopril—ACE—lymph node—ovarian cancer	0.00098	0.011	CbGeAlD
Perindopril—ABCB1—embryo—ovarian cancer	0.000973	0.0109	CbGeAlD
Perindopril—SLC15A2—lymph node—ovarian cancer	0.000855	0.00956	CbGeAlD
Perindopril—ABCB1—epithelium—ovarian cancer	0.000794	0.00888	CbGeAlD
Perindopril—ABCB1—uterine cervix—ovarian cancer	0.000787	0.0088	CbGeAlD
Perindopril—ABCB1—decidua—ovarian cancer	0.00075	0.00839	CbGeAlD
Perindopril—BCHE—lymph node—ovarian cancer	0.000724	0.00809	CbGeAlD
Perindopril—ABCB1—endometrium—ovarian cancer	0.000712	0.00796	CbGeAlD
Perindopril—ABCB1—gonad—ovarian cancer	0.000661	0.00738	CbGeAlD
Perindopril—ABCB1—uterus—ovarian cancer	0.000656	0.00734	CbGeAlD
Perindopril—ABCB1—female reproductive system—ovarian cancer	0.00059	0.00659	CbGeAlD
Perindopril—ABCB1—bone marrow—ovarian cancer	0.000557	0.00623	CbGeAlD
Perindopril—ABCB1—female gonad—ovarian cancer	0.000537	0.006	CbGeAlD
Perindopril—ABCB1—vagina—ovarian cancer	0.000534	0.00596	CbGeAlD
Perindopril—ABCB1—testis—ovarian cancer	0.000476	0.00532	CbGeAlD
Perindopril—ABCB1—lymph node—ovarian cancer	0.000345	0.00386	CbGeAlD
Perindopril—Dyspepsia—Paclitaxel—ovarian cancer	0.00019	0.0007	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00019	0.000698	CcSEcCtD
Perindopril—Stomatitis—Epirubicin—ovarian cancer	0.000189	0.000695	CcSEcCtD
Perindopril—Jaundice—Epirubicin—ovarian cancer	0.000189	0.000695	CcSEcCtD
Perindopril—Urinary tract infection—Epirubicin—ovarian cancer	0.000188	0.000693	CcSEcCtD
Perindopril—Conjunctivitis—Epirubicin—ovarian cancer	0.000188	0.000693	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—ovarian cancer	0.000188	0.000692	CcSEcCtD
Perindopril—Decreased appetite—Paclitaxel—ovarian cancer	0.000188	0.000691	CcSEcCtD
Perindopril—Dry mouth—Docetaxel—ovarian cancer	0.000187	0.000688	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000187	0.000688	CcSEcCtD
Perindopril—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000187	0.000687	CcSEcCtD
Perindopril—Fatigue—Paclitaxel—ovarian cancer	0.000186	0.000686	CcSEcCtD
Perindopril—Sweating—Epirubicin—ovarian cancer	0.000186	0.000684	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—ovarian cancer	0.000186	0.000684	CcSEcCtD
Perindopril—Pain—Paclitaxel—ovarian cancer	0.000185	0.00068	CcSEcCtD
Perindopril—Constipation—Paclitaxel—ovarian cancer	0.000185	0.00068	CcSEcCtD
Perindopril—Haematuria—Epirubicin—ovarian cancer	0.000185	0.00068	CcSEcCtD
Perindopril—Confusional state—Docetaxel—ovarian cancer	0.000185	0.00068	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000184	0.000675	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000183	0.000674	CcSEcCtD
Perindopril—Oedema—Docetaxel—ovarian cancer	0.000183	0.000674	CcSEcCtD
Perindopril—Anaphylactic shock—Docetaxel—ovarian cancer	0.000183	0.000674	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—ovarian cancer	0.000183	0.000673	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—ovarian cancer	0.000182	0.000669	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—ovarian cancer	0.000181	0.000665	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—ovarian cancer	0.00018	0.000664	CcSEcCtD
Perindopril—Shock—Docetaxel—ovarian cancer	0.00018	0.000663	CcSEcCtD
Perindopril—Nervous system disorder—Docetaxel—ovarian cancer	0.00018	0.000661	CcSEcCtD
Perindopril—Thrombocytopenia—Docetaxel—ovarian cancer	0.00018	0.00066	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—ovarian cancer	0.000179	0.00066	CcSEcCtD
Perindopril—Tachycardia—Docetaxel—ovarian cancer	0.000179	0.000658	CcSEcCtD
Perindopril—Feeling abnormal—Paclitaxel—ovarian cancer	0.000178	0.000655	CcSEcCtD
Perindopril—Skin disorder—Docetaxel—ovarian cancer	0.000178	0.000655	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000178	0.000654	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—ovarian cancer	0.000177	0.000652	CcSEcCtD
Perindopril—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000177	0.00065	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—ovarian cancer	0.000176	0.000649	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—ovarian cancer	0.000175	0.000643	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—ovarian cancer	0.000175	0.000643	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—ovarian cancer	0.000175	0.000643	CcSEcCtD
Perindopril—Anorexia—Docetaxel—ovarian cancer	0.000175	0.000643	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—ovarian cancer	0.000175	0.000642	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—ovarian cancer	0.000174	0.000641	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—ovarian cancer	0.000174	0.000641	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—ovarian cancer	0.000174	0.00064	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—ovarian cancer	0.000174	0.00064	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—ovarian cancer	0.000173	0.000635	CcSEcCtD
Perindopril—Sweating—Doxorubicin—ovarian cancer	0.000172	0.000633	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—ovarian cancer	0.000172	0.000632	CcSEcCtD
Perindopril—Urticaria—Paclitaxel—ovarian cancer	0.000172	0.000632	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—ovarian cancer	0.000171	0.000631	CcSEcCtD
Perindopril—Hypotension—Docetaxel—ovarian cancer	0.000171	0.00063	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—ovarian cancer	0.000171	0.000629	CcSEcCtD
Perindopril—Body temperature increased—Paclitaxel—ovarian cancer	0.000171	0.000629	CcSEcCtD
Perindopril—Abdominal pain—Paclitaxel—ovarian cancer	0.000171	0.000629	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—ovarian cancer	0.000171	0.000627	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00017	0.000624	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—ovarian cancer	0.000169	0.000622	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—ovarian cancer	0.000168	0.000619	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—ovarian cancer	0.000168	0.000617	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—ovarian cancer	0.000167	0.000616	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000167	0.000614	CcSEcCtD
Perindopril—Insomnia—Docetaxel—ovarian cancer	0.000166	0.00061	CcSEcCtD
Perindopril—Paraesthesia—Docetaxel—ovarian cancer	0.000165	0.000605	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—ovarian cancer	0.000165	0.000605	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—ovarian cancer	0.000164	0.000603	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—ovarian cancer	0.000163	0.000601	CcSEcCtD
Perindopril—Somnolence—Docetaxel—ovarian cancer	0.000163	0.000599	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—ovarian cancer	0.000163	0.000598	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—ovarian cancer	0.000162	0.000597	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—ovarian cancer	0.000162	0.000595	CcSEcCtD
Perindopril—Flushing—Epirubicin—ovarian cancer	0.000162	0.000594	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—ovarian cancer	0.000162	0.000594	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—ovarian cancer	0.000161	0.000594	CcSEcCtD
Perindopril—Dyspepsia—Docetaxel—ovarian cancer	0.000161	0.000593	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—ovarian cancer	0.000161	0.000592	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—ovarian cancer	0.000161	0.000592	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—ovarian cancer	0.00016	0.000588	CcSEcCtD
Perindopril—Decreased appetite—Docetaxel—ovarian cancer	0.000159	0.000586	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000159	0.000585	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—ovarian cancer	0.000159	0.000583	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000158	0.000582	CcSEcCtD
Perindopril—Fatigue—Docetaxel—ovarian cancer	0.000158	0.000581	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—ovarian cancer	0.000158	0.000581	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—ovarian cancer	0.000158	0.000581	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—ovarian cancer	0.000157	0.000577	CcSEcCtD
Perindopril—Pain—Docetaxel—ovarian cancer	0.000157	0.000577	CcSEcCtD
Perindopril—Constipation—Docetaxel—ovarian cancer	0.000157	0.000577	CcSEcCtD
Perindopril—Chills—Epirubicin—ovarian cancer	0.000156	0.000574	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—ovarian cancer	0.000155	0.000572	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—ovarian cancer	0.000155	0.000571	CcSEcCtD
Perindopril—Asthenia—Paclitaxel—ovarian cancer	0.000155	0.000571	CcSEcCtD
Perindopril—Alopecia—Epirubicin—ovarian cancer	0.000154	0.000566	CcSEcCtD
Perindopril—Pruritus—Paclitaxel—ovarian cancer	0.000153	0.000563	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—ovarian cancer	0.000152	0.000561	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—ovarian cancer	0.000152	0.00056	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—ovarian cancer	0.000152	0.000557	CcSEcCtD
Perindopril—Erythema—Epirubicin—ovarian cancer	0.000152	0.000557	CcSEcCtD
Perindopril—Feeling abnormal—Docetaxel—ovarian cancer	0.000151	0.000556	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—ovarian cancer	0.000151	0.000553	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—ovarian cancer	0.00015	0.000552	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00015	0.000551	CcSEcCtD
Perindopril—Flushing—Doxorubicin—ovarian cancer	0.000149	0.00055	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—ovarian cancer	0.000149	0.00055	CcSEcCtD
Perindopril—Flatulence—Epirubicin—ovarian cancer	0.000149	0.000549	CcSEcCtD
Perindopril—Tension—Epirubicin—ovarian cancer	0.000149	0.000547	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—ovarian cancer	0.000148	0.000546	CcSEcCtD
Perindopril—Diarrhoea—Paclitaxel—ovarian cancer	0.000148	0.000544	CcSEcCtD
Perindopril—Nervousness—Epirubicin—ovarian cancer	0.000147	0.000541	CcSEcCtD
Perindopril—Back pain—Epirubicin—ovarian cancer	0.000147	0.000539	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—ovarian cancer	0.000146	0.000537	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—ovarian cancer	0.000146	0.000536	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000145	0.000534	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—ovarian cancer	0.000145	0.000533	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—ovarian cancer	0.000145	0.000533	CcSEcCtD
Perindopril—Chills—Doxorubicin—ovarian cancer	0.000145	0.000531	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—ovarian cancer	0.000144	0.000529	CcSEcCtD
Perindopril—Dizziness—Paclitaxel—ovarian cancer	0.000143	0.000526	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—ovarian cancer	0.000142	0.000523	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—ovarian cancer	0.000141	0.000519	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—ovarian cancer	0.000141	0.000517	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—ovarian cancer	0.00014	0.000516	CcSEcCtD
Perindopril—Erythema—Doxorubicin—ovarian cancer	0.00014	0.000516	CcSEcCtD
Perindopril—Anaemia—Epirubicin—ovarian cancer	0.00014	0.000515	CcSEcCtD
Perindopril—Agitation—Epirubicin—ovarian cancer	0.000139	0.000512	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—ovarian cancer	0.000138	0.000508	CcSEcCtD
Perindopril—Tension—Doxorubicin—ovarian cancer	0.000138	0.000506	CcSEcCtD
Perindopril—Vomiting—Paclitaxel—ovarian cancer	0.000138	0.000506	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—ovarian cancer	0.000137	0.000505	CcSEcCtD
Perindopril—Malaise—Epirubicin—ovarian cancer	0.000137	0.000502	CcSEcCtD
Perindopril—Rash—Paclitaxel—ovarian cancer	0.000136	0.000502	CcSEcCtD
Perindopril—Dermatitis—Paclitaxel—ovarian cancer	0.000136	0.000501	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—ovarian cancer	0.000136	0.000501	CcSEcCtD
Perindopril—Vertigo—Epirubicin—ovarian cancer	0.000136	0.000501	CcSEcCtD
Perindopril—Syncope—Epirubicin—ovarian cancer	0.000136	0.0005	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—ovarian cancer	0.000136	0.000499	CcSEcCtD
Perindopril—Back pain—Doxorubicin—ovarian cancer	0.000136	0.000499	CcSEcCtD
Perindopril—Headache—Paclitaxel—ovarian cancer	0.000136	0.000498	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—ovarian cancer	0.000135	0.000496	CcSEcCtD
Perindopril—Palpitations—Epirubicin—ovarian cancer	0.000134	0.000492	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—ovarian cancer	0.000133	0.00049	CcSEcCtD
Perindopril—Cough—Epirubicin—ovarian cancer	0.000132	0.000486	CcSEcCtD
Perindopril—Asthenia—Docetaxel—ovarian cancer	0.000132	0.000484	CcSEcCtD
Perindopril—Hypertension—Epirubicin—ovarian cancer	0.000131	0.000481	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00013	0.000478	CcSEcCtD
Perindopril—Pruritus—Docetaxel—ovarian cancer	0.00013	0.000477	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—ovarian cancer	0.00013	0.000477	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—ovarian cancer	0.000129	0.000474	CcSEcCtD
Perindopril—Chest pain—Epirubicin—ovarian cancer	0.000129	0.000474	CcSEcCtD
Perindopril—Myalgia—Epirubicin—ovarian cancer	0.000129	0.000474	CcSEcCtD
Perindopril—Agitation—Doxorubicin—ovarian cancer	0.000129	0.000474	CcSEcCtD
Perindopril—Anxiety—Epirubicin—ovarian cancer	0.000129	0.000473	CcSEcCtD
Perindopril—Nausea—Paclitaxel—ovarian cancer	0.000128	0.000472	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000128	0.000471	CcSEcCtD
Perindopril—Discomfort—Epirubicin—ovarian cancer	0.000127	0.000469	CcSEcCtD
Perindopril—Malaise—Doxorubicin—ovarian cancer	0.000126	0.000465	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—ovarian cancer	0.000126	0.000464	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—ovarian cancer	0.000126	0.000463	CcSEcCtD
Perindopril—Syncope—Doxorubicin—ovarian cancer	0.000126	0.000462	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—ovarian cancer	0.000125	0.000462	CcSEcCtD
Perindopril—Diarrhoea—Docetaxel—ovarian cancer	0.000125	0.000461	CcSEcCtD
Perindopril—Confusional state—Epirubicin—ovarian cancer	0.000125	0.000459	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—ovarian cancer	0.000124	0.000456	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—ovarian cancer	0.000124	0.000455	CcSEcCtD
Perindopril—Oedema—Epirubicin—ovarian cancer	0.000124	0.000455	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—ovarian cancer	0.000123	0.000453	CcSEcCtD
Perindopril—Cough—Doxorubicin—ovarian cancer	0.000122	0.00045	CcSEcCtD
Perindopril—Shock—Epirubicin—ovarian cancer	0.000122	0.000447	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—ovarian cancer	0.000121	0.000446	CcSEcCtD
Perindopril—Dizziness—Docetaxel—ovarian cancer	0.000121	0.000446	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—ovarian cancer	0.000121	0.000445	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—ovarian cancer	0.000121	0.000445	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—ovarian cancer	0.000121	0.000444	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—ovarian cancer	0.00012	0.000442	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—ovarian cancer	0.00012	0.00044	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—ovarian cancer	0.000119	0.000439	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—ovarian cancer	0.000119	0.000439	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—ovarian cancer	0.000119	0.000439	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—ovarian cancer	0.000119	0.000437	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000119	0.000436	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—ovarian cancer	0.000118	0.000434	CcSEcCtD
Perindopril—Anorexia—Epirubicin—ovarian cancer	0.000118	0.000433	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—ovarian cancer	0.000117	0.000429	CcSEcCtD
Perindopril—Vomiting—Docetaxel—ovarian cancer	0.000117	0.000429	CcSEcCtD
Perindopril—Rash—Docetaxel—ovarian cancer	0.000116	0.000425	CcSEcCtD
Perindopril—Hypotension—Epirubicin—ovarian cancer	0.000116	0.000425	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—ovarian cancer	0.000115	0.000425	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—ovarian cancer	0.000115	0.000424	CcSEcCtD
Perindopril—Headache—Docetaxel—ovarian cancer	0.000115	0.000422	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000114	0.000421	CcSEcCtD
Perindopril—Oedema—Doxorubicin—ovarian cancer	0.000114	0.000421	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000113	0.000414	CcSEcCtD
Perindopril—Shock—Doxorubicin—ovarian cancer	0.000113	0.000414	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—ovarian cancer	0.000112	0.000413	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000112	0.000412	CcSEcCtD
Perindopril—Insomnia—Epirubicin—ovarian cancer	0.000112	0.000411	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—ovarian cancer	0.000112	0.000411	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—ovarian cancer	0.000111	0.000409	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—ovarian cancer	0.000111	0.000408	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000111	0.000407	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—ovarian cancer	0.00011	0.000405	CcSEcCtD
Perindopril—Somnolence—Epirubicin—ovarian cancer	0.00011	0.000404	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—ovarian cancer	0.000109	0.000401	CcSEcCtD
Perindopril—Nausea—Docetaxel—ovarian cancer	0.000109	0.0004	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—ovarian cancer	0.000109	0.0004	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—ovarian cancer	0.000108	0.000395	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—ovarian cancer	0.000107	0.000393	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000107	0.000393	CcSEcCtD
Perindopril—Fatigue—Epirubicin—ovarian cancer	0.000107	0.000392	CcSEcCtD
Perindopril—Constipation—Epirubicin—ovarian cancer	0.000106	0.000389	CcSEcCtD
Perindopril—Pain—Epirubicin—ovarian cancer	0.000106	0.000389	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000104	0.000383	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—ovarian cancer	0.000103	0.000381	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—ovarian cancer	0.000103	0.000378	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—ovarian cancer	0.000102	0.000375	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—ovarian cancer	0.000102	0.000375	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—ovarian cancer	0.000102	0.000374	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000101	0.000372	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—ovarian cancer	0.000101	0.00037	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—ovarian cancer	9.95e-05	0.000366	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—ovarian cancer	9.88e-05	0.000363	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—ovarian cancer	9.87e-05	0.000363	CcSEcCtD
Perindopril—Urticaria—Epirubicin—ovarian cancer	9.82e-05	0.000361	CcSEcCtD
Perindopril—Constipation—Doxorubicin—ovarian cancer	9.79e-05	0.00036	CcSEcCtD
Perindopril—Pain—Doxorubicin—ovarian cancer	9.79e-05	0.00036	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—ovarian cancer	9.78e-05	0.000359	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—ovarian cancer	9.78e-05	0.000359	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—ovarian cancer	9.43e-05	0.000347	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—ovarian cancer	9.36e-05	0.000344	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—ovarian cancer	9.09e-05	0.000334	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—ovarian cancer	9.05e-05	0.000333	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—ovarian cancer	9.05e-05	0.000333	CcSEcCtD
Perindopril—Asthenia—Epirubicin—ovarian cancer	8.87e-05	0.000326	CcSEcCtD
Perindopril—Pruritus—Epirubicin—ovarian cancer	8.75e-05	0.000322	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—ovarian cancer	8.46e-05	0.000311	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—ovarian cancer	8.21e-05	0.000302	CcSEcCtD
Perindopril—Dizziness—Epirubicin—ovarian cancer	8.18e-05	0.000301	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—ovarian cancer	8.1e-05	0.000298	CcSEcCtD
Perindopril—Vomiting—Epirubicin—ovarian cancer	7.86e-05	0.000289	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—ovarian cancer	7.83e-05	0.000288	CcSEcCtD
Perindopril—Rash—Epirubicin—ovarian cancer	7.8e-05	0.000287	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—ovarian cancer	7.79e-05	0.000286	CcSEcCtD
Perindopril—Headache—Epirubicin—ovarian cancer	7.75e-05	0.000285	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—ovarian cancer	7.57e-05	0.000278	CcSEcCtD
Perindopril—Nausea—Epirubicin—ovarian cancer	7.35e-05	0.00027	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—ovarian cancer	7.28e-05	0.000268	CcSEcCtD
Perindopril—Rash—Doxorubicin—ovarian cancer	7.21e-05	0.000265	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—ovarian cancer	7.21e-05	0.000265	CcSEcCtD
Perindopril—Headache—Doxorubicin—ovarian cancer	7.17e-05	0.000264	CcSEcCtD
Perindopril—Nausea—Doxorubicin—ovarian cancer	6.8e-05	0.00025	CcSEcCtD
Perindopril—Cilazapril—ABCB1—ovarian cancer	5.97e-05	0.577	CrCbGaD
Perindopril—Enalapril—ABCB1—ovarian cancer	4.38e-05	0.423	CrCbGaD
